Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home
Patients & Consumers Health Professionals District Health Boards Pharmaceutical Suppliers

Wed Nov 25 2009 NZST

Search archive

2009

Your search is limited to one year, search the whole site for archive.

Prev, Next – Page 1 of 12 (118 documents)

icon

Proposal regarding Sigma’s brands of furosemide tablets, ethambutol tablets and atopine eye drops. Closed (2 pages, 56 KB)
2009/10/13
WhatsNew, archive, consultation

13 October 2009 Proposal regarding Sigma’s brands of furosemide tablets (Urex Forte), ethambutol tablets (Myambutol) and atopine eye drops (Atropt) PHARMAC is seeking feedback on a provisional agreement with Sigma Pharmaceuticals (Australia) Pty Ltd regarding furosemide 500 mg tablets, ethambutol…

text


icon

Maori Health Manager vacancy - closes 23 October 09 (1 page, 162 KB)
2009/10/07
WhatsNew, archive, vacancy

At PHARMAC, we make the most of our opportunity to make a difference for New Zealand, including through developing ourselves and our organisational capability. It’s our people that make the difference, so we value them and the commitment and professionalism…

text


icon

Proposal to widen access to tenofovir (Viread) for ‘treatment experienced’ patients with Hepatitis B infection. Closed (3 pages, 100 KB)
2009/09/30
WhatsNew, archive, consultation

30 September 2009 Proposal to widen access to tenofovir (Viread) for ‘treatment experienced’ patients with Hepatitis B infection Summary of Proposal PHARMAC is seeking feedback on a proposal to widen access to tenofovir (Viread) for ‘treatment experienced’ Hepatitis B patients.…

text


icon

Proposal to list a range of Baxter Healthcare’s intravenous and irrigation fluids. Closed (4 pages, 151 KB)
2009/09/25
WhatsNew, archive, consultation

25 September 2009 Proposal to list a range of Baxter Healthcare’s intravenous and irrigation fluids PHARMAC is seeking feedback on a proposal to list a range of intravenous and irrigation fluids supplied by Baxter Healthcare in Part II of Section…

text


icon

Manager, Corporate & External Relations - closes 12 October 2009 (1 page, 159 KB)
2009/09/21
WhatsNew, archive, vacancy

Manager, Corporate & External Relations PHARMAC is the government agency responsible for ensuring New Zealanders have access to a wide range of affordable medicines. As an international leader in pharmaceutical management PHARMAC makes a vital contribution to New Zealand’s health…

text


icon

Programme Manager - Maori Health - closes 25 September 2009 (1 page, 160 KB)
2009/09/07
archive

At PHARMAC, we make the most of our opportunity to make a difference for New Zealand, including through developing ourselves and our organisational capability. It’s our people that make the difference, so we value them and the commitment and professionalism…

text


icon

Proposal for lansoprazole (Solox). Closed (1 page, 140 KB)
2009/09/04
archive, consultation

4 September 2009 Proposal for lansoprazole (Solox) PHARMAC is seeking feedback on a proposal for lansoprazole (Solox) through a provisional agreement with Douglas Pharmaceuticals. Lansoprazole is a proton-pump inhibitor used for various conditions including reflux oesophagitis, duodenal and gastric ulcers.…

text


icon

Proposal to list Dr Reddy’s Risperidone. Closed (1 page, 50 KB)
2009/09/03
archive, consultation

3 September 2009 Proposal for Dr Reddy’s Risperidone PHARMAC is seeking feedback on a proposal to fund a new brand of risperidone tablets (Dr Reddy’s Risperidone) through a provisional agreement with Dr Reddy’s New Zealand Ltd. Key aspects of the…

text


icon

August Tender Results (5 pages, 133 KB)
2009/08/31
archive, notification

31 August 2009 TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept and decline tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender…

text


icon

Approval of agreements with Apotex (for risperidone and topiramate) and Mylan (for risperidone, quetiapine and lithium carbonate) (2 pages, 109 KB)
2009/08/21
archive, notification

21 August 2009 Approval of agreements with Apotex (for risperidone and topiramate) and Mylan (for risperidone, quetiapine and lithium carbonate) PHARMAC is pleased to announce the approval of an agreement with Apotex NZ Ltd to fund a new brand of…

text


Prev, Next – Page 1 of 12 (118 documents)

Search tips

Search or Browse

To search for a document enter a search term into the search form and activate the Search button.

Documents may be browsed by date, eg; Today, November, 2009.

Past years can be browsed too...
2008, 2007, 2006, 2005, 2004, 2003, 2002, 2001, 2000, 1999, 1998.

Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg;
Media releases from 2009

Search terms

Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.

Document tags (shown in bolded red below document date) have highest priority when search results are ranked, followed by title, abstract and full text of document (if available). Tags in use include...
AnnualReport, AnnualReview, archive, BIM, BoardPaper, BusinessPlan, CAC, CACminutes, consultation, delete, EC, ECForm, EOI, etender, herceptin, inpharmation, leaflet, media, notification, OIA, opinion, PatientGuide, policy, poster, PTAC, PTACminutes, PTACSCMinutes, Q&A, release, resource, RFI, RFP, SAForm, SAForms, schedule, SchedulePublications, SectionH, SOI, TAR, tender, update, vacancy, WhatsNew.

Documents with related dates can be browsed through the date component links below the document title.

Remember to group or statements with parentheses if they are beside and statements.

Search examples

consultation
Search for consultations
media and not antibiotics
Search for media related documents that don't mention antibiotics.
(media or consultation) and vaccines
Search for media releases and consultation documents mentioning vaccinations.